{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:22:59Z","timestamp":1770906179645,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Surgery"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1053\/j.sempedsurg.2018.07.008","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T04:26:21Z","timestamp":1532838381000},"page":"237-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Advances in glucagon like peptide-2 therapy. physiology, current indications and future directions"],"prefix":"10.1053","volume":"27","author":[{"given":"D.L.","family":"Sigalet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.sempedsurg.2018.07.008_bib0001","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jpeds.2012.03.062","article-title":"Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium","volume":"161","author":"Squires","year":"2012","journal-title":"J Pediatr"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0002","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0029-1241865","article-title":"Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease","volume":"19","author":"Sigalet","year":"2009","journal-title":"Eur J Pediatr Surg"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0003","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jpedsurg.2010.09.083","article-title":"Elements of successful intestinal rehabilitation","volume":"46","author":"Sigalet","year":"2011","journal-title":"J Pediatr Surg"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0004","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jpedsurg.2005.01.037","article-title":"Neonatal short bowel syndrome: a cohort study","volume":"40","author":"Wales","year":"2005","journal-title":"J Pediatr Surg"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0005","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.3748\/wjg.v12.i26.4117","article-title":"Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation","volume":"12","author":"Martin","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM197806222982505","article-title":"Intestinal adaptation. structural, functional and cytokinetic changes","volume":"298","author":"Williamson","year":"1978","journal-title":"NEJM"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0007","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/gast.2002.31068","article-title":"Biological actions and therapeutic potential of the glucagon-like peptides","volume":"122","author":"Drucker","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0008","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1210\/endo-119-4-1467","article-title":"Glucagon-like peptide GLP-1 and GLP-2, predicted products of the glucagon gene are secreted separately from pig small intestine but not pancreas","volume":"119","author":"Orskov","year":"1986","journal-title":"Endocrinology"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0009","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1139\/y03-107","article-title":"Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2","volume":"81","author":"Brubaker","year":"2003","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/j.gastro.2006.05.055","article-title":"The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice","volume":"131","author":"Dube","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0011","doi-asserted-by":"crossref","first-page":"G431","DOI":"10.1152\/ajpgi.00242.2004","article-title":"Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome","volume":"288","author":"Martin","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0012","doi-asserted-by":"crossref","first-page":"G964","DOI":"10.1152\/ajpgi.00509.2003","article-title":"Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome","volume":"286","author":"Martin","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0013","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","article-title":"Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans","volume":"130","author":"Meier","year":"2006","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1053\/j.sempedsurg.2018.07.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2010.01585.x","article-title":"The effects of glucagon-like peptide 2 on enteric neurons in intestinal inflammation","volume":"22","author":"Sigalet","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpedsurg.2018.02.012","article-title":"Hartmann B and Holst JJ The glucagon-like peptide 2 \u2018axis\u2019: capacity for production and response following intestinal resection or repair of gastroschisis in infants","author":"Sigalet","year":"2018","journal-title":"J Ped Surg"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0016","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1542\/peds.2007-1461","article-title":"Functional ontogeny of the proglucagon derived peptide axis in human neonates","volume":"121","author":"Amin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0017","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.clnu.2016.09.002","article-title":"Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure","volume":"36","author":"Mutanen","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EJE-08-0807","article-title":"Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period","volume":"160","author":"Padidela","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0019","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1442-200X.2006.02255.x","article-title":"Serum glucagon-like peptide-2 levels in neonates: comparison between extremely low-birthweight infants and normal-term infants","volume":"48","author":"Yoshikawa","year":"2006","journal-title":"Pediatr Int"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0020","first-page":"16","article-title":"Regulatory peptides of the gastrointestinal and respiratory tracts","volume":"280","author":"Polak","year":"1986","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0021","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00233271","article-title":"Ontogeny and distribution of certain endocrine cells in the human fetal large intestine. Histochemical and immunocytochemical studies","volume":"203","author":"Lehy","year":"1979","journal-title":"Cell Tissue Res"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1203\/01.PDR.0000134250.80492.EC","article-title":"GLP-2 levels in infants with intestinal dysfunction","volume":"56","author":"Sigalet","year":"2004","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1053\/j.sempedsurg.2018.07.008_bib0023","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/gast.2001.22555","article-title":"Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon","volume":"120","author":"Jeppesen","year":"2001","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.sempedsurg.2018.07.008_bib0024","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut"},{"issue":"4:Suppl 1","key":"10.1053\/j.sempedsurg.2018.07.008_bib0025","first-page":"A","article-title":"Teduglutide, a novel GLP-2 analog, in the management of short-bowel syndrome (SBS) patients dependent on parenteral nutrition: a multicenter multinational placebo-controlled clinical trial","volume":"134","author":"O'Keefe","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0026","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2017.11.023","article-title":"Factors associated with response to Teduglutide in patients with short-bowel syndrome and intestinal failure","volume":"154","author":"Jeppesen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0027","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0148607116680791","article-title":"Independence from Parenteral Nutrition and Intravenous fluid support during treatment with Teduglutide among patients with intestinal failure associated with short bowel syndrome","volume":"41","author":"Iyer","year":"2017","journal-title":"JPEN"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0028","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-week, open-label, multicenter clinical trial of Teduglutide in pediatric short bowel syndrome","volume":"181","author":"Carter","year":"2017","journal-title":"Pediatrics"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0029","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/0148607115609566","article-title":"Safety and dosing study of Glucagon-like peptide 2 in children with intestinal failure","volume":"41","author":"Sigalet","year":"2017","journal-title":"JPEN"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jpedsurg.2017.01.034","article-title":"A safety and pharmacokinetic dosing study of Glucagon-like peptide 2 in infants with intestinal failure","volume":"52","author":"Sigalet","year":"2017","journal-title":"J Ped Surg"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0031","unstructured":"www.Clinicaltrials.gov NCT02949362 Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study Funder: Shire"},{"issue":"8","key":"10.1053\/j.sempedsurg.2018.07.008_bib0032","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/gut.2003.035212","article-title":"Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice","volume":"53","author":"Thulesen","year":"2004","journal-title":"Gut"},{"issue":"9","key":"10.1053\/j.sempedsurg.2018.07.008_bib0033","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1210\/en.2009-0295","article-title":"Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice","volume":"150","author":"Iakoubov","year":"2009","journal-title":"Endocrinology"},{"issue":"19","key":"10.1053\/j.sempedsurg.2018.07.008_bib0034","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1158\/0008-5472.CAN-08-0029","article-title":"Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells","volume":"68","author":"Koehler","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"10.1053\/j.sempedsurg.2018.07.008_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/17474124.2018.1417032","article-title":"Glucagon like peptide-2 and neoplasia; a systematic review","volume":"12","author":"Ring","year":"2018","journal-title":"Exp Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0036","unstructured":"www.Clinicaltrials.gov NCT03408132 Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency Sponsors, Collaborators Funder: GLyPharma Therapeutic."},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1053\/j.sempedsurg.2009.11.005","article-title":"The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function","volume":"19","author":"Sigalet","year":"2010","journal-title":"Semin Pediatr Surg"},{"key":"10.1053\/j.sempedsurg.2018.07.008_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gtc.2007.01.007","article-title":"Growth factors in short-bowel syndrome patients","volume":"36","author":"Jeppesen","year":"2007","journal-title":"Gastroenterol Clin N Am"}],"container-title":["Seminars in Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055858618300593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055858618300593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T20:53:02Z","timestamp":1539809582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055858618300593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1055858618300593"],"URL":"https:\/\/doi.org\/10.1053\/j.sempedsurg.2018.07.008","relation":{},"ISSN":["1055-8586"],"issn-type":[{"value":"1055-8586","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in glucagon like peptide-2 therapy. physiology, current indications and future directions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sempedsurg.2018.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}